Podcast: Emerging Trends in Addiction Medicine
PHI’s CA Bridge save lives by making it possible for people who use drugs to get treatment at any hospital—whenever and wherever they need it.
The Emerging Trends series shares learnings from hospitals that are advancing overdose prevention and treatment, featuring insights from hospitals that are part of the CA Bridge Centers of Excellence project. Topics include: best practices for low-threshold access to buprenorphine treatment for opioid use disorder; emerging treatment pathways for stimulant use disorder; post-overdose care; and more.
Episode 6: Case Studies on Precipitated Withdrawal
Real world case studies on precipitated withdrawal are discussed.
Episode 5: Just Start It: Buprenorphine Self-Starts
Starting patients in withdrawal on buprenorphine is safe – so safe in fact, patients can successfully do it on their own. We’ll talk through the details of how to prescribe buprenorphine self-starts and the coaching for patients that goes with it.
Episode 4: Innovations in Post Overdose Care
Starting post-overdose buprenorphine is safe and saves lives at a moment when patients are most at risk for a repeat overdose and death. Combining effective treatment with suicide screening can save even more lives.
Presenters: Leslie Mukau, MD and Aimee Moulin, MD
Episode 3: New Best Practices in Harm Reduction: Fentanyl Test Strips, HCV/HIV Testing, and More
Naloxone saves lives, but a functioning take-home naloxone program should be just one component of wraparound harm reduction services from the emergency room. Learn the latest best practices including fentanyl test strips, STD testing, and more
Presenters: Josh Luftig, PA-C and Arianna Sampson, PA-C
Episode 2: Precipitated Withdrawal: What You Need to Know
Precipitated withdrawal prompted by buprenorphine initiation doesn't have to be scary for the patient or provider. Learn how to avoid it with smart and proven treatment.
Episode 1: Buprenorphine Starts for Fentanyl Use
Facts vs Fear: As fentanyl spreads in many communities, buprenorphine is still an effective tool for treating patients with just a few clinical tweaks.
Presenters: Hannah Snyder, MD & Erik Andersen, MD